A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and omega-3 fatty acids in HIV-infected patients. Swiss HIV Cohort Study

AIDS. 1998 Jan 1;12(1):53-63. doi: 10.1097/00002030-199801000-00007.

Abstract

Objective: To evaluate the effects of an oral nutritional supplement enriched with two potentially immunostimulant compounds (arginine and omega-3 fatty acids) on the changes in food intake, body composition, immune parameters and viraemia in HIV-infected outpatients.

Design: Six-month prospective randomized double-blind controlled study.

Setting: University hospital outpatient nutrition clinic.

Patients: Sixty-four HIV-infected outpatients with CD4 lymphocyte count > or = 10O x 10(6)/l.

Intervention: All patients received a daily oral nutritional supplement (606 kcal supplemented with vitamins, trace elements and minerals). In addition, half of the patients were randomized to receive 7.4 g arginine plus 1.7 g omega-3 fatty acids.

Main outcome measures: Disease progression measured by AIDS-defining events, CD4 and CD8 lymphocyte counts, viraemia, tumour necrosis factor soluble receptors, nutritional status determined by anthropometric, bioelectrical impedance and dietetic assessment.

Results: Fifty-five patients completed the protocol. Compliance with and tolerance of oral nutritional supplement during the 6-month period was excellent. In both groups of patients the following were found: total energy intake was transiently increased and then returned to baseline level; nitrogen/energy intake ratio was increased throughout the study; gain of body weight and fat mass were approximately 2 and 1kg, respectively, over 6 months, and were similar in both groups. In addition, CD4 and CD8 lymphocyte counts, viraemia, tumour necrosis factor soluble receptors remained statistically unchanged and were similar in both groups.

Conclusions: Enrichment of an oral nutritive supplement with arginine and omega-3 fatty acids did not improve immunological parameters. However, body weight increased in both groups.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Immunodeficiency Syndrome / diagnosis
  • Adult
  • Arginine / administration & dosage
  • Arginine / therapeutic use*
  • Body Composition
  • Body Weight
  • CD4 Lymphocyte Count
  • CD8-Positive T-Lymphocytes / immunology
  • Dietary Supplements*
  • Double-Blind Method
  • Eating
  • Electric Impedance
  • Fatty Acids, Omega-3 / administration & dosage
  • Fatty Acids, Omega-3 / therapeutic use*
  • Feeding Behavior
  • Female
  • HIV Infections / diagnosis
  • HIV Infections / diet therapy*
  • HIV Infections / immunology
  • Humans
  • Lymphocyte Count
  • Male
  • Minerals / administration & dosage
  • Outpatients
  • Patient Compliance
  • Quality of Life
  • Receptors, Tumor Necrosis Factor / analysis
  • Receptors, Tumor Necrosis Factor / metabolism
  • Viremia / diagnosis
  • Viremia / metabolism
  • Vitamins / administration & dosage
  • Weight Gain

Substances

  • Fatty Acids, Omega-3
  • Minerals
  • Receptors, Tumor Necrosis Factor
  • Vitamins
  • Arginine